Setting a new standard for the future of pharma

Almaject® Inc. is a wholly owned subsidiary of Alvogen, specializing in the commercialization of generic injectable pharmaceuticals for the acute and alternate site healthcare markets in the US.

Almaject is a combination of the Latin word Alma, which means nourishing, fostering, and kind, with “ject” referring to injectables. Together, Almaject strives to earn customer loyalty for our portfolio of injectables by fostering partnerships built on integrity and trust.

Our portfolio of generic injectable pharmaceuticals for the acute and alternate site healthcare markets in the US. The current portfolio of injectables covers a broad range of therapeutic areas.